Targeting MYC in small cell lung cancer: Bridging molecular subtypes and therapeutic vulnerability.
Small cell lung cancer (SCLC) is one of the most aggressive and rapidly progressing forms of lung cancer, characterized by its high proliferative rate and strong tendency to metastasize. Although SCLC initially responds well to platinum-based chemotherapy, resistance typically develops quickly, leaving few effective op...